germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...

Fundació Institut d'Investigació
en Ciències de la Salut
Germans Trias i Pujol
Balana Quintero C; GENOM.
The Spanish Group of Medical Neuro‐Oncology. GENOM.
Clin Transl Oncol 2006 Jun;8(6):388‐90.
Batra S, Shi Y, Kuchenbecker KM, He B, Reguart N, Mikami I, You L, Xu ZD, Lin YC, Clement G, Jablons DM.
Wnt inhibitory factor‐1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma.
BIOCHEM BIOPH RES CO 2006; 342(4):1228‐1232.
2,855
Camps C, Massuti B, Jimenez A, Maestu I, Gomez RG, Isla D, Gonzalez JL, Almenar D, Blasco A, Rosell R, Carrato A, Vinolas N,
Batista N,Giron CG, Galan A, Lopez M, Blanco R, Provencio M, Diz P, Felip E.
Randomized phase III study of 3‐weekly versus weekly docetaxel in pretreated advanced non‐small‐cell lung cancer: a Spanish
Lung Cancer Group trial.
ANN ONCOL 2006; 17(3):467‐472.
5,179
Carrato C, Beyer K, Zamora L, Granada I, Roussos I, Balana C, Milla F, Ariza A.
1p/19q loss in gliomas: Microsatellite amplification in comparison with FISH.
MODERN PATHOL 2006; 19:284A‐284A.
3,753
Carrato C, Beyer K, Zamora L, Granada I, Roussos I, Balana C, Milla F, Ariza A.
1p/19q loss in gliomas: Microsatellite amplification in comparison with FISH.
LAB INVEST 2006; 86:284A‐284A.
4,453
Coma G, Pena R, Blanco J, Rosell A, Borras FE, Este JA, Clotet B, Ruiz L, Parkhouse RME, Bofill M.
Treatment of monocytes with interleukin (IL)‐12 plus IL‐18 stimulates survival, differentiation and the production of CXC
chemokine ligands (CXCL)8, CXCL9 and CXCL10.
CLIN EXP IMMUNOL 2006; 145(3):535‐544.
2,747
de las Penas R, Sanchez‐Ronco M, Alberola V, Taron M, Camps C, Garcia‐Carbonero R, Massuti B, Queralt C, Botia M, Garcia‐
Gomez R, Isla D, Cobo M, Santarpia M, Cecere F, Mendez P, Sanchez JJ, Rosell R.
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine‐treated non‐small‐cell lung cancer patients.
ANN ONCOL 2006; 17(4):668‐675.
5,179
Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, Gonzales‐Larriba JL, Grodzki T, Pereira JR, Le Groumellec A, Lorusso V,
Clary C, Torres AJ, Dahabreh J, Souquet PJ, Astudillo J, Fournel P, Artal‐Cortes A, Jassem J, Koubkova L, His P, Riggi M, Hurteloup P.
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB‐IIIA non‐small‐cell lung
cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.
LANCET ONCOL 2006 Sep;7(9):719‐27
10,119
Felip E, Rosell R.
Clinical experience with erlotinib in non‐small‐cell lung cancer.
DRUGS TODAY 2006; 42(3):147‐156.
1,503
Gamez C, Rosell R, Fernandez A, Andia E, Arnaiz MD, Cardenal F, Lorenzo C.
PET/CT fusion scan in lung cancer: Current recommendations and innovations.
J THORAC ONCOL 2006; 1(1):74‐77.
0
Juarez A, Camps C, Sirera R, Llobat L, Safont MJ, Berrocal A, Blasco A, Garde J, Munoz‐Navarro M, Taron M, Rosell R.
Analysis of nerve growth factor (NGF) blood levels in patients with advanced non‐small cell lung cancer (NSCLC): Its correlation
with clinical outcome.
LUNG CANCER‐J IASLC 2006; 52:S23‐S23.
Pàgina 160/177